Comparison between multivessel stenting with drug eluting to the LAD and bilateral internal thoracic artery grafting
- PMID: 16401540
- DOI: 10.1532/HSF98.20051107
Comparison between multivessel stenting with drug eluting to the LAD and bilateral internal thoracic artery grafting
Abstract
Background: Reduction of restenosis and reinterventions was reported with drug-eluting stents (Cypher). This study compares results of multivessel Cypher stenting with bilateral internal thoracic artery (BITA) grafting.
Methods: From January 2002 to June 2004, 725 consecutive patients underwent multivessel myocardial revascularization, 95 by 2 or more Cypher stents and 630 by BITA. After matching for age, sex, and extent of coronary artery disease, 2 groups (87 patients each) were used to compare the 2 revascularization modalities.
Results: The 2 groups were similar; however, left main and the use of an intra-aortic balloon pump were more prevalent in the BITA group. The number of coronary vessels treated per patient was higher in the BITA group (2.71 versus 2.24 for BITA and Cypher, respectively; P = .001). Mean follow-up was 12 months. Thirty-day mortality was 0 in both groups. There were no late deaths in the BITA group and 2 (2.3%) in the Cypher group (P value was not significant). Angina returned in 29.9% of the Cypher group and 12.6% of the BITA group (P = .005). Multivariable Cox analysis revealed percutaneous intervention (PCI) (Cypher group) to be the only independent predictor of angina recurrence (Odds Ratio 2.62, 95% Confidence Interval 1.11-6.17). There were 10 reinterventions (PCI) in the Cypher group compared to 5 in the BITA group. One-year reintervention-free survival (Kaplan-Meier) of the BITA group was 96% compared to 88% in the Cypher group (P = .015).
Conclusions: Midterm clinical outcome of surgically treated patients is still better. However, the reintervention gap between surgery and percutaneous interventions was reduced by treating 2 or more coronary vessels with Cypher stents.
Similar articles
-
Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease.Ann Thorac Surg. 2005 Dec;80(6):2086-90. doi: 10.1016/j.athoracsur.2005.05.053. Ann Thorac Surg. 2005. PMID: 16305850
-
Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus.Ann Thorac Surg. 2006 Nov;82(5):1692-7. doi: 10.1016/j.athoracsur.2006.05.080. Ann Thorac Surg. 2006. Retraction in: Ann Thorac Surg. 2007 Aug;84(2):712. PMID: 17062230 Retracted.
-
Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus.J Thorac Cardiovasc Surg. 2006 Oct;132(4):861-6. doi: 10.1016/j.jtcvs.2006.04.055. J Thorac Cardiovasc Surg. 2006. Retraction in: J Thorac Cardiovasc Surg. 2007 Sep;134(3):730. doi: 10.1016/j.jtcvs.2007.07.011. PMID: 17000298 Retracted.
-
[Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].Herz. 2008 Apr;33(3):196-205. doi: 10.1007/s00059-008-3121-5. Herz. 2008. PMID: 18568314 Review. German.
-
Comparison of bilateral thoracic artery grafting with percutaneous coronary interventions in diabetic patients.Ann Thorac Surg. 2004 Aug;78(2):471-5; discussion 476. doi: 10.1016/j.athoracsur.2004.02.038. Ann Thorac Surg. 2004. PMID: 15276499 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous